- 學位論文
以預凝膠法製備磷酸鈣/海藻膠之核/殼奈米粒子並應用於酸鹼應答型的藥物釋放
Synthesis of calcium phosphate/alginate core/shell nanoparticles (CaP@alginate) through pre-gel method as pH-responsive drug carriers
並列摘要
A new drug nanovehicle consisting of inorganic calcium phosphate (CaP) nanoparticle as core and organic alginate as shell (denoted as CaP@alginate) has been successfully synthesized via a pre-gel method and applied for pH-sensitive drug delivery systems (DDS). The CaP@alginate nanocomposite contains both advantages of CaP and alginate, where CaP provides pH-responsive degradability and alginate provides excellent biocompatibility and COOH functionality. Through the sequent addition of CaCl2 and phosphate solutions into alginate solution, CaP@alginate nanocomposites with controllable particle sizes (ranging from 160 to 650 nm) were obtained, and the core-shell structure of the CaP@alginate was observed under transmission electron microscopy (TEM). Rhodamine 6G (R6G), a positively charged and water-soluble dye, was selected as a model drug for pH-sensitive DDS. R6G was encapsulated in the nanocomposites during synthesis, and its loading efficiency can reach up to ca. 63.0%. The in vitro release behavior of the loaded R6G at different pH values was systematically studied, and the results indicated that more R6G molecules were released at lower pH conditions. For example, after release for 8 hours, the release amount of R6G at pH 2.0 was 2.53-fold of that at pH 7.4. We attributed this pH-sensitive release behavior to the dissolution of the CaP core at acidic conditions, and this pH-responsive behavior was expected to enhance the selective delivery of internal cargos. The results of MTT assay and confocal laser scanning microscopes indicated CaP@alg were successfully uptaken by HepG2 cells without apparent cytotoxicity. The CaP@alginate nanocomposites synthesized in this report show great potential as drug nanovehicles with high biocompatibility, specific targeting, and pH-responsible features for intracellular DDS in the future.
參考文獻
被引用紀錄
延伸閱讀
- Ni, H. C. (2008). 製備不同型態結構的硫酸化軟骨素-聚己內酯奈米粒子作為具標的功能的藥物載體 [master's thesis, Kaohsiung Medical University]. Airiti Library. https://doi.org/10.6832/KMU.2008.00175
- 林依穎、江伯源（2018）。海藻酸鈉／幾丁聚醣／澱粉－複合乳化凝膠球粒（晶球）成型機制及其品質影響探討。臺灣農業化學與食品科學，56(3&4)，101-111。https://doi.org/10.6578/TJACFS.201808_56(3&4).0006
- 巢育誠、陳忠益、黃國雄、張志鵬（2007）。W/O/W型海藻酸鈣膠囊之製備及其制放性的探討。華岡紡織期刊，14(2)，111-117。https://doi.org/10.29984/JHGT.200706.0002
- 王毓襄（2015）。研發含聚麩胺酸及明膠之水膠攜帶 TGF-β1之磷酸鈣水泥於活髓治療之研究：材料物理性質、生物活性、生物相容性及動物實驗〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2015.02115
- Liang, Y. C. (2009). I. Synthesis of magnetic carbon nanoparticles using microwave arcing process and growth mechanism. II. Growth mechanism of vertically aligned carbon nanotubes. [doctoral dissertation, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-1111200916045793